Lisa Michelle Kallebo

CIK: 0002000724

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ADCT

ADC Therapeutics SA

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

ADCT
ADC Therapeutics SA
Feb 13, 2026
Award(A)
Direct
62.9K shares at avg. $3.99$251K
ADCT
ADC Therapeutics SA
Feb 13, 2026
Tax Payment(F)
Direct
5.4K shares at avg. $3.99$22K
ADCT
ADC Therapeutics SA
Dec 6, 2025
Tax Payment(F)
Direct
7.1K shares at avg. $3.29$23K
ADCT
ADC Therapeutics SA
Feb 13, 2025
Award(A)
Direct
41.9K shares at avg. $1.61$67K
ADCT
ADC Therapeutics SA
Dec 6, 2024
Tax Payment(F)
Direct
6.5K shares at avg. $3.13$20K

		Type	Shares	Price		Ownership
Feb 13, 2026	ADCT ADC Therapeutics SA	Award(A)	62,900	$3.99	$250,971	Direct
Feb 13, 2026	ADCT ADC Therapeutics SA	Tax Payment(F)	5,433	$3.99	$21,678	Direct
Dec 6, 2025	ADCT ADC Therapeutics SA	Tax Payment(F)	7,140	$3.29	$23,491	Direct
Feb 13, 2025	ADCT ADC Therapeutics SA	Award(A)	41,900	$1.61	$67,459	Direct
Dec 6, 2024	ADCT ADC Therapeutics SA	Tax Payment(F)	6,503	$3.13	$20,354	Direct

1-5 of 5 transactions

About Kallebo Lisa Michelle

Kallebo Lisa Michelle (SEC CIK 0002000724) files insider reports with the SEC as Chief Accounting Officer of ADC Therapeutics SA (ADCT).

Signal8 holds 4 ownership filings by Kallebo Lisa Michelle, all Form 4s, filed between Dec 9, 2024 and Feb 18, 2026. Those filings report 5 transactions, from Dec 6, 2024 to Feb 13, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kallebo Lisa Michelle's filings is in NEW PROVIDENCE, NJ.

Recent filings by Kallebo Lisa Michelle

Feb 13, 2026: Grant or award of ADCT shares (Form 4, code A).
Feb 13, 2026: Tax withholding of ADCT shares (Form 4, code F).
Dec 6, 2025: Tax withholding of ADCT shares (Form 4, code F).
Feb 13, 2025: Grant or award of ADCT shares (Form 4, code A).
Dec 6, 2024: Tax withholding of ADCT shares (Form 4, code F).

Other insiders filing for ADC Therapeutics SA (ADCT)

Zaki Mohamed, Chief Medical Officer
GRAHAM PETER J, Chief Legal Officer
Carmona Jose, Chief Financial Officer
MALLIK AMEET, Chief Executive Officer
Azelby Robert, Director
Squarer Ron, Director

How to read Form 4 transaction codes